Published On: November 18th, 2010
Jennifer Corbett Dooren discusses a study involving Merck’s experimental drug anacetrapib, the results of which showed it met safety goals while significantly boosting good cholesterol levels and lowering the bad kind.

Here is the original post:
News Hub: Merck Cholesterol Drug Hits Safety Goals/a>
Loading...
Leave a comment



Did you know:





